Get started
Author

Natalie Marlen

Observed names: N. Marlen, NATALIE MARLEN, Natalie A. Marlen
ORCID: 0000-0002-3192-8149
Observed ORCID: 0000-0002-3192-8149
OpenAlex ID: A5014257686
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
2018 · Maria J. Redondo, Susan Geyer, et al. · Diabetes Care · 174
Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
2012 · David N. Abarbanel, Scott M. Seki, et al. · Journal of Clinical Immunology · 121
Fourteen Year Follow-Up of Randomized Clinical Trials of Active Robotic-Assisted Total Hip Arthroplasty
2017 · William L. Bargar, Carol A. Parise, et al. · The Journal of Arthroplasty · 89
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes
2025 · Michael J. Haller, Lauren Kanapka, et al. · Diabetes Care · 8
PDF
Treatment Experience of Children with Growth Hormone Deficiency in the Phase 3 fliGHt Trial: Switching from Daily Growth Hormone to Once-weekly TransCon hGH
2020 · Donna Campbell, Kimberly Walsh, et al. · Journal of Pediatric Nursing · 2
PDF
640-P: The Association of Happiness and Resilience with Glycemic Control in Pediatric Type 1 Diabetes Mellitus
2022 · RESHMIKA RAMESH, GA YOUNG BYEON, et al. · Diabetes
Continued Efficacy and Safety with up to 2 Years of Treatment with Lonapegsomatropin (TransCon hGH) in Children with Growth Hormone Deficiency
2021 · Donna Campbell, Kimberly Walsh, et al. · Journal of Pediatric Nursing
Works count: 7
Citation count: 394
H-index: 4
I10-index: 3
Year
Topic
Type